ArticleFrontiers in endocrinology2026

Efficacy and safety of bevacizumab plus XELOX in patients with unresectable locally advanced or metastatic neuroendocrine tumors.

Huike Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.